MINK1 and breast cancer: In this work, the activation of JNK and its downstream effector molecule c-Jun was attenuated in breast cancer cells overexpressing miR-17-5p or subjected to MINK1 knockdown, whereas miR-17-5p downregulation or MINK1 upregulation led to opposing outcomes.